glp-1 patent expiration 8 key drug patents expiring soon — and what it means for the market How to Survive the GLP-1

We also provide ongoing monitoring and check-ins, so youre never left guessing about your progress

It does not significantly raise IGF-1 or systemic growth hormone levels

(McElroy has previously consulted for Eli Lilly, Novo Nordisk, and other companies.) One case, published in 2025, involved a woman who had been treated for anorexia as a child and was later prescribed tirzepatide for diabetes, hypertension, and liver issues

Thinking About Taking a GLP-1 Medication

While the peptide does not appear to develop traditional tolerance or suppress natural healing processes, periodic breaks allow for natural healing integration and reduce cumulative exposure

Mild gastrointestinal symptoms (transient nausea, vomiting, abdominal cramps, and diarrhoea) have been reported